Kitty Lee is a principal in Oliver Wyman’s Health & Life Science practice based in Singapore. She has over 14 years of advisory and operational experience across Asia, Europe and the U.S., with the last six years based in Asia. Kitty’s work focuses on supporting clients on various M&A and value creation agendas, from pre-transaction assessments of sources of value and risk to supporting the implementation of value-creation topics. Additionally, she leverages her five years line experience in the health industry to help clients on operational transformation and commercial innovation topics.